Typing of Ochrobactrum anthropi clinical isolates using automated repetitive extragenic palindromic-polymerase chain reaction DNA fingerprinting and matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry
© Quirino et al.; licensee BioMed Central Ltd. 2014
Received: 5 September 2013
Accepted: 18 March 2014
Published: 22 March 2014
Ochrobactrum anthropi (O. anthropi), is a non-fermenting gram-negative bacillus usually found in the environment. Nevertheless, during the past decade it has been identified as pathogenic to immunocompromised patients. In this study, we assessed the usefulness of the automated repetitive extragenic palindromic-polymerase chain reaction (rep-PCR-based DiversiLab™ system, bioMèrieux, France) and of matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF MS) for typing of twentythree O. anthropi clinical isolates that we found over a four-months period (from April 2011 to August 2011) in bacteriemic patients admitted in the same operative unit of our hospital. Pulsed-field gel electrophoresis (PFGE), commonly accepted as the gold standard technique for typing, was also used. Analysis was carried out using the Pearson correlation coefficient to determine the distance matrice and the unweighted pair group method with arithmetic mean (UPGMA) to generate dendogram.
Rep-PCR analysis identified four different patterns: three that clustered together with 97% or more pattern similarity, and one whose members showed < 95% pattern similarity. Interestingly, strains isolated later (from 11/06/2011 to 24/08/2011) displayed a pattern with 99% similarity. MALDI-TOF MS evaluation clustered the twentythree strains of O. anthropi into a single group containing four distinct subgroups, each comprising the majority of strains clustering below 5 distance levels, indicating a high similarity between the isolates.
Our results indicate that these isolates are clonally-related and the methods used afforded a valuable contribution to the epidemiology, prevention and control of the infections caused by this pathogen.
KeywordsOchrobactrum anthropi rep-PCR fingerprinting MALDI-TOF MS Strain typing
Ochrobactrum anthropi (O. anthropi) is a non-fermenting, aerobic, gram-negative bacillus that exhibits widespread resistance to β-lactam antibiotics [1, 2] and is able to colonize a variety of environments, namely soil, plants, insects, animals and humans . Reports of opportunistic/nosocomial infections caused by O. anthropi have been increasing over the last decade [4–6], and the ability of O. anthropi to adhere to silicone may play a role in catheter-associated infections [6, 7]. Furthermore, O. anthropi populations may adapt in response to habitat and host interactions, as previously described in human clinical isolates [3, 8]. In the human infection: a catheter-associated bacteremia caused by O. anthropi has been shown . In literature, the infections due to O. anthropi involved catheter related bacteremia, whereas endophalmitis, urinary infections, meningitis, endocarditis, hepatic, pelvic and pancreatic abscess often as monomicrobial infection have been reported [1, 4, 6, 9]
According to their habitat, the population structure of O. anthropi varied. For example, biological and genomic microdiversity was higher in bulk soil than in the rhizoshere [10, 3]. Authors related this difference in diversity level to the expansion of clones adapted to metabolites produced by rhizodeposition .
Among the few publications regarding the known methods for typing of O. anthropi relevant papers are those from Romano et al., 2010  dealing with MLST and PFGE. Also, Bathe et al., 2006  described the rep-PCR of O. anthropi (however with a instrument different than Diversilab, bioMerieux). Finally, Bizzini et al., 2010  reported on Maldi-TOF characterization of O. anthropi.
The different typing methods used, mainly rep-PCR and Maldi-TOF, in terms of time, accuracy and costs may allow to obtain more timely, accurate results with higher resolution among the different strains involved in hospital outbreak. When this infection did occur in our hospital, we set out to study the identification and typing of the twentythree O. anthropi strains. Strain typing was carried out by automated repetitive extragenic palindromic-polymerase chain reaction (rep-PCR-based DiversiLabTM system, bioMèrieux, France) and by pulsed-field gel electrophoresis (PFGE). Proteome profiling was performed through matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF MS).
The application of accurate and more powerful techniques, used for typing, should be encouraged for monitoring the spread of bacteria and nosocomial infection control.
Bacterial strains and microbiological methods
During a 4-month period (from April 2011 to August 2011) 23 O. anthropi strains were isolated from samples of 19 patients admitted to the Catanzaro University Hospital (Italy) Oncology O.U. Samples were taken as part of standard patient care and all procedures were approved by the local ethics committee at the Medical Faculty of the University “Magna Graecia” of Catanzaro, which are in compliance with Declaration of Helsinki (59th WMA General Assembly, Seoul, October 2008).
O. anthropi strains isolated from patients admitted to the Oncology O.U.
Date of isolation
Rep-PCR-based DNA fingerprinting by the DiversiLab System
For rep-PCR analysis, bacteria (23 clinical strains of O. anthropi, in addition to O. anthropi ATCC49188T and O. intermedium LMG3301T, kind gifts from Dr. Fabien Aujoulat, Universitè Montpellier, France) were grown on Columbia blood agar; DNA was extracted from a 10-μl loopful of each O. anthropi colony, using an UltraClean Microbial DNA isolation kit (Mo Bio Laboratories, Carlsbad, CA). The extracted DNA was amplified using a DiversiLab Generic DNA fingerprinting kit (bioMèrieux, France), following the manufacturer’s instructions. DiversiLab Rep-PCR was performed according to Treviño M. et al., 2011 . Briefly, 50 ng of genomic DNA, 2.5 U of AmpliTaq DNA polymerase, and 1.5 μl of 10× PCR buffer (Applied Biosystems, Foster City, CA) were added to the appropriate rep-PCR master mix to achieve a total of 25 μl. Thermal cycling parameters were as follows: initial denaturation at 94°C for 2 min, 35 cycles of denaturation at 94°C for 30 s, annealing at 60°C for 30 s, extension at 70°C for 90 s, and final extension at 70°C for 3 min. DNA concentration was measured by NANODROP 1000 Spectrophotometer (Thermo Scientific). The amplified product was stored at -20°C until detection. Analysis of rep-PCR products was performed using a DiversiLab system, in which the amplified fragments of various sizes and intensities are separated and detected using a microfluidic LabChip by an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). The relatedness of the isolates was analysed by means of the DiversiLab software, version 3.4, using the Pearson correlation coefficient, to determine distance matrices, and the unweighted-pair group method with arithmetic mean (UPGMA). Further analysis was performed by the Kullback–Leibler distance correlation coefficient.
In general, “different” was defined as <95% pattern similarity and 2 or more band differences for organisms defined as homogeneous, and three or more band differences for organisms defined as heterogeneous. “Similar” was defined as >95% and <97.% pattern similarity and one band difference for homogeneous organisms, or up to two band differences for heterogeneous organisms. “Indistinguishable” was defined as >97% pattern similarity and no band differences, including no variation in the intensities of individual bands, although overall intensities may differ .
Genotyping by PFGE
The 23 O. anthropi isolates were grown overnight and suspended in SE buffer (75 mM NaCl, 25 mM EDTA, pH 7.5). The cell suspensions (4 McFarland units) were mixed with an equal volume of 2% low-melting point agarose, moulded into plugs at 4°C, and lysed with lysis buffer (1% N-lauryl sarcosine, 0.5 M EDTA, pH 8) supplemented with Proteinase K (500 μg/mL). The DNA contained in each plug was digested by 20 U of SpeI restriction enzyme in accordance with the manufacturer's instructions. Macrorestriction fragments were separated using the CHEF-DR III PFGE system (Bio-Rad) at 10°C for 20 h, at a field strength of 6 V/cm, with an initial switch time of 5 s and a final switch time of 35 s. A lambda ladder of phage DNA concatemers was used as a size marker. O. anthropi ATCC 49188 T and O. intermedium LMG 3301 T were also genotyped by PFGE, and fragment patterns were compared according to the criteria described by Tenover .
MALDI-TOF MS and data analysis
A single colony grown overnight on TSI (Triple Sugar Iron) agar was spotted in duplicate onto the MALDI target (MSP 96 target polished steel (MicroScoutTarget) plate; (Bruker Daltonik, Bremen, Germany) and air-dried at room temperature. After air-drying, each spot was overlaid with 1 μL of HCCA (a-cyano-4-hydroxycinnamic acid) matrix solution saturated with organic solvent (50% acetonitrile and 2.5% trifluoroacetic acid) and air-dried completely before MALDI-TOF MS. MALDI-TOF MS was carried out using a MALDI Microflex LT. Peptide mass fingerprint product ion spectra were acquired in linear positive mode at a laser frequency of 20 Hz, within a mass range from 2000 to 20 000 Da. For each spectrum, 240 laser shots were automatically acquired in 40 shot steps from different positions of the target spot (random walk movement) using AutoXecute acquisition control software (Flexcontrol 3.0; Bruker Daltonics, Bremen, Germany). The spectra were externally calibrated using the standard calibrant mixture (Escherichia coli extracts supplemented by proteins RNase A and myoglobin; Bruker Daltonics). To identify unknown bacteria, each peak list generated was matched directly against reference libraries (3502 species). Unknown spectra were compared with a library of reference spectra by means of a pattern-recognition algorithm making use of peak position, peak intensity distributions and peak frequencies. MALDI-TOF identifications were classified using modified versions of the score values proposed by the manufacturer: a score ≥2 indicated species identification, a score in the range 1.7-1.99 indicated genus identification, and a score <1.7 denotes no identification. For the phylogenetic data analysis, a total of 16 spectra were automatically acquired with the AutoXecute acquisition control software for each strain (biological and technical replicates). MSP creation was carried out with the default setting of the Biotyper software (desired mass error for the MSP: 200; desired peak frequency minimum: 25%; maximum desired peak number for the MSP: 70). Each Minimum spanning trees (MSP) was assigned to its specific node on the taxonomy tree. In order to visualize the relationship between the MSPs, dendrogram clustering was carried out using the standard settings of MALDI Biotyper software version 2.0 (distance measure: correlation; linkage: average). In addition, to evaluate the spectral variation within each strain, the composite correlation index (CCI) was computed by loading the raw data into the Biotyper software .
All isolated strains exhibited the same biochemical pattern (excellent identification: 99%) and presented an overlapping antimicrobial susceptibility profile – they were all sensitive to gentamicin (<1 μg/ml), tobramycin (<1 μg/ml), amikacin (16 μg/ml), ciprofloxacin (<0.25 μg/ml), levofloxacin (0.25 μg/ml), imipenem (2 μg/ml), and sulfamethoxazole/trimethoprim (<20 μg/ml), and resistant to ampicillin (>32 μg/ml), ampicillin/sulbactam (>32 μg/ml), cefazolin (>64 μg/ml), cefepime (>64 μg/ml), cefoxitine (>64 μg/ml), ceftazidime (>64 μg/ml), ceftriaxone (>64 μg/ml), piperacillin/tazobactam (>128 μg/ml) and nitrofurantoin (256 μg/ml). The negative Brucella agglutination sera test supported the biochemical identification.
Rep-PCR-based DNA fingerprinting
MALDI-TOF MS data
O. anthropi is an adaptable bacterial species, whose individual strains can thrive in different environments. Indeed, after its molecular characterization  human-associated clonal complex data appear to indicate it possesses a specialized opportunistic behaviour . It is frequently isolated from contaminated medical materials/devices and specimens obtained from immunocompromised patients , and after the first recognized case of human disease induced by this organism , O. anthropi infections causing primary or catheter-associated bacteraemia [1, 17] have been increasingly reported . With this in mind, when this infection did occur in our hospital, we set out to study the identification and typing of the O. anthropi strains through the genomic and proteomic correlation. To our knowledge, this represents the first study on strain typing of O. anthropi where the use of both rep-PCR and MALDI-TOF-MS-based fingerprinting were carried out. All patients developed infection during their stay in hospital, and in our Institution no cases of infection due to O. anthropi had been diagnosed before. Environmental and flushing solution cultures were negative for O. anthropi, therefore the source of the infection strains remained unclear. Fluoroquinolone monotherapy yielded good clinical response, however blood cultures from all patients became negative only after removal of CVC.
Our results indicate that all investigated strains were highly related and that they arose from a common ancestor, strongly providing evidence for a clonal origin of the infection. Interestingly, the strains detected early on during the outbreak showed a great variability in correlation range (90%–99%), while bacteria isolated later showed a correlation higher than 99%. We can therefore speculate that O. anthropi is able to undergo rapid modifications, allowing bacteria to adapt to a human host. The proteomic profiles, which clustered the 23 strains in a single group, unrelated to the ATCC isolates present in the database (one of which comes from leech urine), further suggest a clonal origin of the infections. Moreover strains studied showed phylogenetically different patterns from ATCC reference strains used in all methods employed and different cluster patterns under rep-PCR fingerprinting and MALDI-TOF. A likely explanation for these differences could be that rep-PCR analysis embraces the entire bacterial chromosome, whereas the main signals reported in MALDI-TOF MS are generated from ribosomal proteins alone [18, 13]. Since we studied a small number of strains, we can’t draw firm conclusions about the correlation between automated rep-PCR and MALDI-TOF for molecular typing of Ochrobactrum anthropi. However, both methods have demonstrated a similar sensitivity in discriminating the variability among the strains studied. Although strict comparison between PFGE and MALDI-TOF was problematic, due to the different methods involved (i.e., protein profiling for MALDI-TOF dendrogram and genetic profiling for PFGE), the tests showed a similar separation between the CZ1552 strain and the other strains. Although the results obtained by the two techniques were similar, on the whole, MALDI-TOF results were obtained much more rapidly, within a few minutes. MALDI-TOF is not only much easier and less-time consuming than PFGE, it also requires a limited amount of bacterial colonies and allows comparison at all times with the universal database.
Semi-automated rep-PCR appeared to be more discriminative than PFGE in typing the 23 O. anthropi strains isolated during this hospital outbreak. Both rep-PCR and MALDI-TOF MS yielded four clusters and a common ancestor, while PFGE showed the same PFGE profile in 22 isolates. In PFGE, strain CZ1552 was the odd one out, whereas rep-PCR identified strain CZ1424 as being different. These strains were found to be genetically unrelated to each other.
The marker used for the rep-PCR analysis (the region between the noncoding repetitive sequences in bacterial genomes) is less genetically stable than the one used for PFGE (the target sequence of the SpeI restriction enzyme). Hence, the variability shown by rep-PCR is likely to represent changes in the same clone that could not be detected by PFGE . Rep-PCR analysis is a technique aimed at defining clonal relationships, and its ease of use and faster turnaround time as compared to PFGE makes it a rapid method of screening outbreaks of O. anthropi and therefore allows timely implementation of control measures.
In conclusion, rep-PCR and MALDI-TOF MS appear to be extremely useful for evaluation of clonal relationships between isolates. The different marker (genomic vs. proteomic) evaluated, as well as the completely different techniques used increase the reliability with which isolate similarity or diversity may be assessed during a hospital outbreak. In addition, we believe that advances in the molecular typing of Ochrobactrum anthropi would facilitate the study on the epidemiology, prevention and control of the infections caused by this pathogen.
- O. anthropi:
Repetitive extragenic palindromic-polymerase chain reaction
Matrix-assisted laser desorption/ionization-time-of-flight
Pulsed-field gel electrophoresis
Unweighted pair group method with arithmetic mean
Central venous catheter
- O. intermedium:
Triple Sugar Iron
Minimum spanning trees
Composite correlation index.
- Soloaga R, Carrion N, Pidone J, Guelfand L, Margari A, Altieri R: Catheter-associated bacteremia caused by Ochrobactrum anthropi. Medicina (B Aires). 2009, 69 (suppl.6): 655-657.Google Scholar
- Nadjar D, Labia R, Cerceau C, Bizet C, Philippon A, Arlet G: Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrum anthropi. Antimicrob Agents Chemother. 2001, 45 (suppl.8): 2324-2330.PubMed CentralView ArticlePubMedGoogle Scholar
- Romano S, Aujoulat F, Jumas-Bilak E, Masnou A, Jeannot JL, Falsen E, Marchandin H, Teyssier C: Multilocus sequence typing supports the hypothesis that Ochrobactrum anthropi displays a human-associated subpopulation. BMC Microbiol. 2009, 9: 267-10.1186/1471-2180-9-267. doi:10.1186/1471-2180-9-267PubMed CentralView ArticlePubMedGoogle Scholar
- Daxboeck F, Zitta S, Assadian O, Krause R, Wenisch C, Kovarik J: Ochrobactrum anthropi bloodstream infection complicating hemodialysis. Am J Kidney Dis. 2002, 40 (suppl. 4): E17-PubMedGoogle Scholar
- Shrishrimal K: Recurrent: Ochrobactrum anthropi and Shewanella putrefaciens bloodstream infection complicating hemodialysis. Hemodial Int. 2011, doi:10.1111/j.1542-4758.2011.00586.xGoogle Scholar
- Wi YM, Peck KR: Biliary sepsis caused by Ochrobactrum anthropi. Jpn J Infect Dis. 2010, 63 (suppl.6): 444-446.PubMedGoogle Scholar
- Song S, Ahn JK, Lee GH, Park YG: An epidemic of chronic pseudophakic endophthalmitis due to Ochrobactrum anthropi: clinical findings and managements of nine consecutive cases. Ocul Immunol Inflamm. 2007, 15 (suppl.6): 429-434.PubMed CentralView ArticlePubMedGoogle Scholar
- van Dijck P, Delmée M, Ezzedine H, Deplano A, Struelens MJ: Evaluation of pulsed-field gel electrophoresis and rep-PCR for the epidemiological analysis of Ochrobactrum anthropi strains. Eur J Clin Microbiol Infect Dis. 1995, 14 (suppl.12): 1099-1102.View ArticlePubMedGoogle Scholar
- Naik C, Kulkarni H, Darabi A, Bhanot N: Ochrobactrum anthropi: a rare cause of pneumonia. J Infect Chemother. 2013, 19 (1): 162-5. 10.1007/s10156-012-0436-1.View ArticlePubMedGoogle Scholar
- Lebuhn M, Achouak W, Schloter M, Berge O, Meier H, Barakat M, Hartmann A, Heulin T: Taxonomic characterization of Ochrobactrum sp. Isolates from soil samples and wheat roots, and description of Ochrobactrum tritici sp. nov. and Ochrobactrum grignonense sp. nov. Int J Syst Evol Microbiol. 2000, 50: 2207-2223. 10.1099/00207713-50-6-2207.View ArticlePubMedGoogle Scholar
- Bathe S, Achouak W, Hartmann A, Heulin T, Schloter M, Lebuhn M: Genetic and phenotypic microdiversity of Ochrobactrum spp. FEMS Microbiol Ecol. 2006, 56 (suppl.2): 272-280.View ArticlePubMedGoogle Scholar
- Bizzini A, Jaton K, Romo D, Bille J, Prod’hom G, Greub G: MALDI-TOF Mass Spectrometry as an alternative to 16S rDna sequencing for identification of difficult to identify bacterial strains. J Clin Microbiol. 2010, doi:10.1128/JCM.01463-10Google Scholar
- Treviño M, Navarro D, Barbeito G, García-Riestra C, Crespo C, Regueiro BJ: Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight. Microb Drug Resist. 2011, 17 (3): 433-442. 10.1089/mdr.2010.0182. doi:10.1089/mdr.2010.0182View ArticlePubMedGoogle Scholar
- Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995, 33: 2233-2239.PubMed CentralPubMedGoogle Scholar
- Pulcrano G, Roscetto E, Iula VD, Panellis D, Rossano F, Catania MR: MALDI-TOF mass spectrometry and microsatellite markers to evaluate Candida parapsilosis transmission in neonatal intensive care units. Eur J Clin Microbiol Infect Dis. 2012, 31: 2919-2928. 10.1007/s10096-012-1642-6.View ArticlePubMedGoogle Scholar
- Appelbaum PC, Campbell DB: Pancreatic abscess associated with Achromobacter group Vd biovar 1. J Clin Microbiol. 1980, 12: 282-283.PubMed CentralPubMedGoogle Scholar
- Cieslak TJ, Robb ML, Drabick CJ, Fischer GW: Catheter-associated sepsis caused by Ochrobactrum anthropi: report of a case and review of related nonfermentative bacteria. Clin Infect Dis. 1992, 14 (suppl.4): 902-907.View ArticlePubMedGoogle Scholar
- Treviño M, Navarro D, Barbeito G, Areses P, García-Riestra C, Regueiro BJ: Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF. Rev Esp Quimioter. 2012, 25 (2): 122-8.PubMedGoogle Scholar
- Ligozzi M, Fontana R, Aldegheri M, Scalet G, Lo Cascio G: Comparative evaluation of an automated repetitive-sequence-based PCR instrument versus pulsed-field gel electrophoresis in the setting of a Serratia marcescens nosocomial infection outbreak. J Clin Microbiol. 2010, 48 (5): 1690-5. 10.1128/JCM.01528-09.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.